Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

686
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
686
X-linked Traits01:19

X-linked Traits

53.0K
In most mammalian species, females have two X sex chromosomes and males have an X and Y. As a result, mutations on the X chromosome in females may be masked by the presence of a normal allele on the second X. In contrast, a mutation on the X chromosome in males more often causes observable biological defects, as there is no normal X to compensate. Trait variations arising from mutations on the X chromosome are called “X-linked”.
53.0K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

597
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
597
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

300
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
300
Introduction to Hemostasis01:05

Introduction to Hemostasis

5.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.1K
Sex-linked Disorders01:43

Sex-linked Disorders

99.9K
Like autosomes, sex chromosomes contain a variety of genes necessary for normal body function. When a mutation in one of these genes results in biological deficits, the disorder is considered sex-linked.
99.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Another step toward phenotypic characterization of hereditary dysfibrinogenemia?

Research and practice in thrombosis and haemostasis·2026
Same author

Successful Treatment of Heavy Menstrual Bleeding in a Woman With Mild Haemophilia A Using Efanesoctocog Alfa.

Haemophilia : the official journal of the World Federation of Hemophilia·2026
Same author

An Unusual Association Between Acquired Hemophilia A and Type 2 Autoimmune Pancreatitis.

Hamostaseologie·2026
Same author

Outpatient drug therapy for children with heart disease in Switzerland: a survey.

European journal of pediatrics·2026
Same author

Current Indications for Thrombophilia Testing - A Modified Delphi Consensus Study in Switzerland.

Hamostaseologie·2026
Same author

The Swiss Haemophilia Registry-Report From the First 8 Years.

Haemophilia : the official journal of the World Federation of Hemophilia·2026

Related Experiment Video

Updated: May 27, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.0K

Women and Hereditary Bleeding Disorders.

Alessandra Bosch1, Dehlia Moussaoui2, Alessandro Casini3

  • 1Department of Haematology, University Children's Hospital Zurich, Eleonore Foundation, Zurich, Switzerland.

Hamostaseologie
|February 19, 2025
PubMed
Summary

Hereditary bleeding disorders disproportionately affect women, causing significant gynecological and obstetric complications. This review highlights these challenges and discusses hormonal management strategies for heavy menstrual bleeding (HMB).

More Related Videos

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.1K

Related Experiment Videos

Last Updated: May 27, 2025

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
08:13

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice

Published on: September 30, 2021

6.0K
In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time
09:19

In Vitro Microfluidic Disease Model to Study Whole Blood-Endothelial Interactions and Blood Clot Dynamics in Real-Time

Published on: May 24, 2020

8.8K
Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.1K

Area of Science:

  • Hematology
  • Gynecology
  • Obstetrics

Background:

  • Hereditary bleeding disorders are hemostasis defects impacting both sexes.
  • Historically, research and clinical focus have centered on male patients, particularly hemophilia.
  • This has led to an underappreciation of the impact on women's health.

Purpose of the Study:

  • To summarize the unique characteristics of hereditary bleeding disorders in women.
  • To emphasize the clinical challenges faced by women with these conditions.
  • To review hormonal management strategies for heavy menstrual bleeding (HMB).

Main Methods:

  • This is a review article.
  • It synthesizes existing literature on hereditary bleeding disorders in women.
  • Focuses on gynecological and obstetric complications and management.

Main Results:

  • Women with hereditary bleeding disorders face distinct challenges, including heavy menstrual bleeding (HMB), miscarriage complications, postpartum hemorrhage, and ovarian cysts.
  • Delays in diagnosis and treatment are common, leading to anemia, anxiety, and reduced quality of life.
  • Hormonal management is a key strategy for HMB.

Conclusions:

  • Hereditary bleeding disorders present specific health issues for women, often overlooked in traditional research.
  • Timely diagnosis and tailored management are crucial to mitigate complications like anemia and improve quality of life.
  • Further research and clinical attention are needed to address the full spectrum of these disorders in women.